LSLing Sun

Ling Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ling Sun has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Association Between Serum α 1‐Acid Glycoprotein and Obesity and Abdominal Obesity in Women: A Cross‐Sectional Study Based on NHANES Data From 2015 to 2018

    by Ling Sun, Lingyan He, Hao Zhang, Bruno Fink, Haihua Pan, Changlin Zhai

    Background: Obesity and abdominal obesity are major public health issues closely related to metabolic diseases. Serum α 1‐acid glycoprotein (SSAGP), an acute‐phase reactant influenced by inflammation and metabolic status, has an unclear relationship with obesity and abdominal obesity. This study investigates this association in women. Methods: Using cross‐sectional data from NHANES (2015–2018), 2219 adult women were divided into three groups based on SSAGP levels (low, medium, and high). Multiple regression analyses assessed the relationship between SSAGP and BMI, waist circumference, obesity (BMI ≥ 30 kg/m 2 ), and abdominal obesity (waist circumference ≥ 90 cm). Threshold and interaction analyses were also conducted. Results: As SSAGP levels increased, BMI, waist circumference, fasting blood glucose, insulin, and hs‐CRP levels rose significantly ( p < 0.001), while HDL levels decreased ( p < 0.001). SSAGP was positively correlated with BMI, waist circumference, obesity, and abdominal obesity ( p < 0.0001). After adjusting for confounders, a one‐unit increase in SSAGP was associated with a 4.42 increase in BMI (95% CI: 3.08, 5.76), a 12.18 cm increase in waist circumference (95% CI: 9.22, 15.14), a 3.63‐fold increase in obesity risk (95% CI: 1.96, 6.72), and a 10.75‐fold increase in abdominal obesity risk (95% CI: 4.85, 23.85). Threshold effect analysis showed an inflection point ( K = 1.2), with SSAGP having a stronger promoting effect below this point and an inhibitory effect above it ( p < 0.001). Educational level significantly influenced the SSAGP‐obesity relationship ( p = 0.0096). Conclusion: SSAGP levels are significantly associated with obesity and abdominal obesity in women, with educational level playing a modulatory role. SSAGP may serve as a potential biomarker for obesity risk. Future studies should explore the causal relationships and underlying mechanisms.


  • Open Access

    Identification and validation of ANXA3 and SOCS3 as biomarkers for acute myocardial infarction related to sphingolipid metabolism

    by Ling Sun, Lingyan He, Hai-Hua Pan, Chang-Lin Zhai

    Background: Sphingolipid metabolism (SM) is linked to acute myocardial infarction (AMI), but its role remains unclear. This study explored SM-related genes (SMRGs) in AMI to support clinical diagnosis. Methods: We analyzed datasets GSE48060 and GSE123342 to identify differentially expressed genes (DEGs) and key module genes. Protein-protein interaction (PPI) network analysis and machine learning were used to screen potential biomarkers, which were validated via receiver operating characteristic (ROC) curves and expression assessment. Further analyses included artificial neural networks (ANN), enrichment analysis, immune infiltration, drug prediction, and molecular docking. Single-cell RNA sequencing (scRNA-seq) identified key cell types and their functions. Biomarkers were validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: Intersection of 95 DEGs and 2,196 module genes yielded 20 genes, with ANXA3 and SOCS3 identified as biomarkers. The ANN model showed superior diagnostic performance compared to individual markers. Biomarkers were enriched in the toll-like receptor (TLR) signaling pathway. Immune infiltration analysis revealed differences in five immune cell types between AMI and control groups. ANXA3 correlated positively with neutrophils and negatively with resting memory CD4 T cells. Drugs targeting ANXA3 included ethanolamine, difluocortolone, and fluocinolone acetonide, with strong binding affinity. scRNA-seq identified B cells and monocytes as key cells; ANXA3 and SOCS3 expression increased during monocyte differentiation before decreasing, while B cells showed no significant changes. Conclusion: ANXA3 and SOCS3 were identified as SM-related biomarkers in AMI, providing insights for clinical diagnosis.


  • Open Access

    Association Between Cardiometabolic Index and Blood Pressure: A Cross-Sectional Analysis of the NHANES 2015–2018 Data

    by Lingyan He, Ling Sun, Haihua Pan, Changlin Zhai

    Background: Hypertension is a major risk factor for cardiovascular diseases (CVDs) and is closely related to metabolic abnormalities. The cardiometabolic index (CMI) integrates lipid profiles and anthropometric indicators, reflecting overall cardiometabolic health. However, the CMI and blood pressure (BP) relationship is poorly understood. Therefore, this study aimed to investigate the correlation between CMI and clinical BP and evaluate the potential of using this correlation as a cardiovascular risk indicator. Methods: National Health and Nutrition Examination Survey (NHANES) data from 2015 to 2018 were used to calculate the CMI based on the triglycerides to high-density lipoprotein cholesterol ratio and the waist-to-height ratio. The relationship between CMI and systolic blood pressure (SBP)/diastolic blood pressure (DBP) was analyzed using multivariate regression, threshold effect analysis, and subgroup analysis. Results: In this study cohort of 4240 participants, CMI positively correlated with SBP and DBP. After adjusting for age, gender, and race, the partial correlation for SBP was 0.56 (95% CI: 0.19–0.93; p < 0.01), while for DBP, it was 1.15 (95% CI: 0.60–1.71; p < 0.001). The threshold effect analysis revealed a positive association with SBP when the CMI was below 6.83 (β = 1.44, 95% CI: 0.64–2.24; p < 0.001) and a negative association when the CMI was above 6.83 (β = –1.52, 95% CI: –2.77– –0.28; p = 0.0123). For the DBP, a positive correlation was found when the CMI was below 2.81 (β = 1.45, 95% CI: 0.10–2.79; p = 0.0345), and a negative correlation when the CMI was above 2.81 (β = –1.92, 95% CI: –3.08– –0.77; p = 0.0012). A strong interaction was observed between the CMI and gender for the SBP (p = 0.0054) and a trend for the interaction between CMI and age for the DBP (p = 0.1667). Conclusions: This study found a significant positive correlation between the CMI and BP, with threshold effects supporting a non-linear relationship. The strong interaction between the CMI and gender for SBP suggests that the influence of the CMI on BP may be gender-dependent. These results highlight the importance of utilizing CMI in personalized cardiovascular risk stratification and underscore the relevance of considering patient factors such as gender in managing hypertension.